Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

BMYMP Financial Statements and Analysis

PNK : BMYMP

Bristol-Myers Squibb Company PFD CONV 2

$900.55
0.55+0.06%
Open: 3:00 PM

BMYMP FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

BMYMP Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue11.892B12.201B11.865B11.477B10.966B
cost of revenue2.957B5.40B2.91B2.745B2.506B
gross profit8.935B6.801B8.955B8.732B8.46B
gross profit ratio0.7510.5570.7550.7610.771
research and development expenses2.374B2.295B2.346B2.478B2.242B
general and administrative expenses00-378.00M5.838B0
selling and marketing expenses1.983B02.367B-3.765B2.003B
selling general and administrative expenses1.983B1.922B1.989B2.073B2.003B
other expenses0458.00M-2.357B-272.00M565.00M
operating expenses8.935B4.217B6.692B6.829B6.501B
cost and expenses9.604B9.617B9.602B9.574B9.007B
interest income000145.00M107.00M
interest expense505.00M521.00M425.00M316.00M280.00M
depreciation and amortization2.592B2.561B2.555B2.464B2.435B
ebitda4.773B4.368B-8.536B4.148B4.959B
ebitda ratio0.4010.4220.3750.3610.452
operating income2.172B2.584B2.263B1.684B4.215B
operating income ratio0.1830.2120.1910.1470.384
total other income expenses net-496.00M-1.298B-13.03B87.00M458.00M
income before tax1.676B1.286B-11.516B1.674B2.137B
income before tax ratio0.1410.105-0.9710.1460.195
income tax expense461.00M-398.00M392.00M-88.00M203.00M
net income1.211B1.68B-11.911B1.762B1.928B
net income ratio0.1020.138-1.0040.1540.176
eps9.2412.782-90.7060.870.94
eps diluted9.2412.782-90.7060.870.93
weighted average shs out131.82M131.755M131.495M2.027B2.057B
weighted average shs out dil132.015M131.885M131.495M2.033B2.064B
Graph

BMYMP Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents7.89B6.295B9.33B11.464B7.514B
short term investments204.00M360.00M340.00M816.00M171.00M
cash and short term investments8.094B6.655B9.67B12.28B7.685B
net receivables14.895B15.146B14.06B15.264B15.647B
inventory3.332B3.077B2.985B2.662B2.436B
other current assets1.754B2.014B1.952B1.509B1.81B
total current assets28.075B26.89B28.669B31.77B27.632B
property plant equipment net8.251B8.161B8.186B8.036B7.848B
goodwill21.751B21.732B21.738B21.169B21.147B
intangible assets26.964B29.839B33.167B27.485B29.377B
goodwill and intangible assets48.715B51.571B54.905B48.654B50.524B
long term investments2.853B3.00B2.226B2.063B1.882B
tax assets3.609B3.323B2.723B2.768B1.514B
other non current assets2.167B1.701B2.322B1.868B1.863B
total non current assets65.595B67.756B70.362B63.389B63.631B
other assets00000
total assets93.67B94.646B99.031B95.159B91.263B
account payables3.469B3.751B3.539B3.259B2.813B
short term debt1.243B3.708B6.359B3.281B5.617B
tax payables1.489B1.474B1.487B1.371B1.458B
deferred revenue02.691B3.86B4.224B3.865B
other current liabilities16.437B14.332B14.437B11.498B11.167B
total current liabilities22.638B23.265B25.822B22.262B23.462B
long term debt50.157B50.296B51.05B38.183B33.65B
deferred revenue non current247.00M263.00M282.00M300.00M316.00M
deferred tax liabilities non current430.00M461.00M442.00M338.00M399.00M
other non current liabilities2.998B3.292B4.887B4.591B4.374B
total non current liabilities53.832B54.312B56.661B43.412B38.739B
other liabilities00000
capital lease obligations1.648B1.438B1.732B1.692B1.663B
total liabilities76.47B77.577B82.483B65.674B62.201B
preferred stock00000
common stock292.00M292.00M292.00M292.00M292.00M
retained earnings16.097B16.103B15.64B28.766B28.218B
accumulated other comprehensive income loss-1.468B-1.456B-1.40B-1.546B-1.286B
other total stockholders equity2.221B2.076B1.958B1.918B1.774B
total stockholders equity17.142B17.015B16.49B29.43B28.998B
total equity17.20B17.069B16.548B29.485B29.062B
total liabilities and stockholders equity93.67B94.646B99.031B95.159B91.263B
minority interest58.00M54.00M58.00M55.00M64.00M
total investments3.057B3.36B340.00M2.879B171.00M
total debt51.40B54.004B57.409B41.464B39.267B
net debt43.51B47.709B48.079B30.00B31.753B
Graph

BMYMP Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
deferred income tax-256.00M-331.00M-711.00M-1.327B-327.00M
stock based compensation129.00M125.00M133.00M127.00M132.00M
change in working capital2.173B-2.371B198.00M855.00M291.00M
accounts receivables661.00M-1.019B479.00M536.00M-659.00M
inventory-218.00M-225.00M-218.00M-197.00M-256.00M
accounts payables-374.00M-259.00M300.00M444.00M-268.00M
other working capital2.141B-868.00M-1.273B72.00M1.474B
other non cash items-301.00M7.412B12.971B371.00M286.00M
net cash provided by operating activities5.591B2.326B2.834B4.252B4.751B
investments in property plant and equipment-324.00M-262.00M-284.00M-330.00M-342.00M
acquisitions net-859.00M-1.103B-19.812B-340.00M-79.00M
purchases of investments-40.00M-84.00M-274.00M-717.00M-502.00M
sales maturities of investments238.00M130.00M752.00M41.00M513.00M
other investing activites766.00M-262.00M241.00M00
net cash used for investing activites-219.00M-1.319B-19.618B-1.346B-410.00M
debt repayment-18.753B-2.80B-15.953B-2.00B-10.00M
common stock issued000010.00M
common stock repurchased0000-4.00B
dividends paid-1.216B-1.217B-1.212B-1.16B-1.191B
other financing activites16.117B-6.00M15.856B4.127B31.00M
net cash used provided by financing activities-3.852B-4.023B14.644B967.00M-5.16B
effect of forex changes on cash77.00M-22.00M-45.00M78.00M-38.00M
net change in cash1.598B-3.037B-2.185B3.951B-857.00M
cash at end of period7.893B6.295B9.334B11.519B7.568B
cash at beginning of period6.295B9.332B11.519B7.568B8.425B
operating cashflow5.591B2.326B2.834B4.252B4.751B
capital expenditure-324.00M-262.00M-284.00M-330.00M-342.00M
free cash flow5.267B2.064B2.55B3.922B4.409B
Graph

Frequently Asked Questions

How did Bristol-Myers Squibb Company PFD CONV 2 do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, BMYMP generated $11.89B in revenue last quarter, while its costs came in at $2.96B.

Last quarter, how much Gross Profit did Bristol-Myers Squibb Company PFD CONV 2 report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Bristol-Myers Squibb Company PFD CONV 2 reported a $8.94B Gross Profit for the quarter ended Sep 30, 2024.

Have BMYMP's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. BMYMP incurred $8.94B worth of Operating Expenses, while it generated $2.17B worth of Operating Income.

How much Net Income has BMYMP posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Bristol-Myers Squibb Company PFD CONV 2, the company generated $1.21B in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Bristol-Myers Squibb Company PFD CONV 2 have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Bristol-Myers Squibb Company PFD CONV 2 as of the end of the last quarter was $7.89B.

What are BMYMP's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, BMYMP had Total Net Receivables of $14.90B.

In terms of Total Assets and Current Assets, where did Bristol-Myers Squibb Company PFD CONV 2 stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of BMYMP were $28.08B, while the Total Assets stand at $93.67B.

As of the last quarter, how much Total Debt did Bristol-Myers Squibb Company PFD CONV 2 have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of BMYMP's debt was $51.40B at the end of the last quarter.

What were BMYMP's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, BMYMP reported total liabilities of $76.47B.

How much did BMYMP's Working Capital change over the last quarter?

Working Capital Change for BMYMP was $2.17B over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

BMYMP generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. BMYMP generated $5.59B of Cash from Operating Activities during its recently reported quarter.

What was BMYMP's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. BMYMP reported a $1.60B Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph